甘李药业(603087)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603087 甘李药业

已收盘 12-20 15:00:00

{"stockData":{"symbol":"603087","market":"SH","secType":"STK","nameCN":"甘李药业","latestPrice":45.77,"timestamp":1734678000000,"preClose":45.53,"halted":0,"volume":3819820,"delay":0,"floatShares":554000000,"shares":601000000,"eps":0.9664,"marketStatus":"已收盘","marketStatusCode":5,"change":0.24,"latestTime":"12-20 15:00:00","open":45.55,"high":45.99,"low":45.37,"amount":175000000,"amplitude":0.0136,"askPrice":45.77,"askSize":2,"bidPrice":45.76,"bidSize":43,"shortable":0,"etf":0,"ttmEps":0.9664,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":45.53,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":50.08,"lowLimit":40.98,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":601065290,"pbRate":2.45,"roa":"--","roe":"4.61%","epsLYR":0.6,"committee":-0.347826,"marketValue":27511000000,"floatMarketCap":25353000000,"peRate":47.36134,"changeRate":0.0053,"turnoverRate":0.0069,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-12-23。"},"requestUrl":"/m/hq/s/603087/wiki","defaultTab":"wiki","newsList":[{"id":"2492175350","title":"甘李药业12月19日主力资金流出689万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2492175350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492175350?lang=zh_cn&edition=full","pubTime":"2024-12-19 15:20","pubTimestamp":1734592805,"startTime":"0","endTime":"0","summary":"12月19日, 甘李药业股价涨0.33%，报收45.53元，成交金额1.75亿元，换手率0.70%，振幅1.85%，量比0.45。甘李药业今日主力资金净流出689万元，连续3日净流出，上一交易日主力净流出1777万元，今日环比减少61.23%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为68.18%，平均跌幅为1.67%。该股近5个交易日下跌1.09%，主力资金累计净流出5306万元，其中3个交易日为股价上涨时净流出；近20日主力资金累计净流出2.25亿元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219160616ab83e6a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219160616ab83e6a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2491615938","title":"甘李药业控股股东解押24万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491615938","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491615938?lang=zh_cn&edition=full","pubTime":"2024-12-16 20:57","pubTimestamp":1734353820,"startTime":"0","endTime":"0","summary":"财中社12月16日电甘李药业 发布关于公司控股股东及实际控制人部分股份解押的公告。控股股东甘忠如持有公司股份2.06亿股，占公司总股本的34.21%。在2024年12月16日，公司收到通知，甘忠如已办理完毕24万股公司股份的解押登记手续。截至公告披露日，甘忠如的剩余被质押股份为2821万股，占其所持股份的13.72%，占公司总股本的4.69%。2024年前三季度，甘李药业实现收入22.45亿元，归母净利润5.07亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216210326a1f31abc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216210326a1f31abc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2491340347","title":"甘李药业：公司现阶段会在定期报告中披露报告期末的股东情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2491340347","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491340347?lang=zh_cn&edition=full","pubTime":"2024-12-13 18:00","pubTimestamp":1734084013,"startTime":"0","endTime":"0","summary":"证券之星消息，甘李药业12月13日在投资者关系平台上答复投资者关心的问题。截止2024年9月30日，公司股东人数为77,899。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300034101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2491318983","title":"甘李药业控股股东解押2650万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491318983","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491318983?lang=zh_cn&edition=full","pubTime":"2024-12-12 18:16","pubTimestamp":1733998563,"startTime":"0","endTime":"0","summary":"控股股东甘忠如持有公司34.21%的股份，近期办理了2650万股的解押登记，解除质押后，甘忠如及其控制的北京旭特宏达合计持有的股份占公司总股本的41.82%。目前，甘忠如及旭特宏达累计质押的股份为3935万股，占其持股的15.65%，占公司总股本的6.55%。公告指出，甘忠如的剩余被质押股份数量为2845万股，占其所持股份的13.83%，占公司总股本的4.73%。2024年前三季度，甘李药业实现收入22.45亿元，归母净利润5.07亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212182940a1e8d06e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212182940a1e8d06e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2490808980","title":"甘李药业(603087.SH)：GZR18注射液获得FDA药品临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2490808980","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490808980?lang=zh_cn&edition=full","pubTime":"2024-12-12 18:08","pubTimestamp":1733998118,"startTime":"0","endTime":"0","summary":"智通财经APP讯，甘李药业(603087.SH)发布公告，公司全资子公司甘李药业美国公司获得美国食品药品监督管理局批准，同意GZR18注射液进行Ⅱ期临床试验(IND171618)。甘李药业自主开发的GZR18注射液是一种长效GLP-1受体激动剂，旨在治疗成人2型糖尿病及肥胖/超重个体的体重管理。公司此前已经完成中国地区的Ⅱ期临床试验，临床研究数据表明GZR18注射液每周和每两周给药一次均能实现良好的降糖或减重效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1224097.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1141","03347","603087","BK0239","BK1576"],"gpt_icon":0},{"id":"2490808649","title":"甘李药业最新公告：美国子公司获得FDA药品临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2490808649","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490808649?lang=zh_cn&edition=full","pubTime":"2024-12-12 17:51","pubTimestamp":1733997070,"startTime":"0","endTime":"0","summary":"甘李药业公告，公司全资子公司甘李药业美国公司获得美国食品药品监督管理局批准，同意GZR18注射液进行Ⅱ期临床试验。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200030584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603087","BK1141","03347","BK1576","BK1583"],"gpt_icon":0},{"id":"2490870547","title":"甘李药业：美国子公司GZR18注射液获FDA临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2490870547","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490870547?lang=zh_cn&edition=full","pubTime":"2024-12-12 17:47","pubTimestamp":1733996833,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["GLP","603087","BK1576","BK4590","BK4144","BK0239","03347","BK1141","BK1583"],"gpt_icon":0},{"id":"2489286140","title":"甘李药业12月06日主力资金流出228万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2489286140","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489286140?lang=zh_cn&edition=full","pubTime":"2024-12-06 15:21","pubTimestamp":1733469694,"startTime":"0","endTime":"0","summary":"12月06日, 甘李药业股价涨0.68%，报收45.88元，成交金额2.83亿元，换手率1.11%，振幅2.70%，量比1.20。甘李药业今日主力资金净流出228万元，连续5日净流出，上一交易日主力净流出2173万元，今日环比减少89.51%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为38.46%，平均跌幅为2.74%。该股近5个交易日下跌0.46%，主力资金累计净流出7287万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出2.59亿元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206154311ab61f42b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206154311ab61f42b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2489473677","title":"甘李药业股东减持计划不影响股权稳定，业绩增长措施积极","url":"https://stock-news.laohu8.com/highlight/detail?id=2489473677","media":"GPLP犀牛财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489473677?lang=zh_cn&edition=full","pubTime":"2024-12-06 13:17","pubTimestamp":1733462245,"startTime":"0","endTime":"0","summary":"作者：KimSu近日，甘李药业股份有限公司发布公告称，公司股东旭特宏达计划在3个月内，通过集中竞价方式最高减持601万余股。对此，甘李药业表示，此次减持计划对公司股权结构的整体稳定性影响不大，不会导致控制权变化或重大股权结构调整。甘李药业强调，公司目前股权架构稳定，经营持续向好，对未来发展持有积极预期。不过甘李药业也将在优化销售策略和成本控制的同时，确保销售费用的使用效率最大化，支撑可持续的业绩增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206131736ab61ac99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206131736ab61ac99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2489535172","title":"回购推高股价方便减持？甘李药业百亿富豪甘忠如卷入争议","url":"https://stock-news.laohu8.com/highlight/detail?id=2489535172","media":"雷达财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489535172?lang=zh_cn&edition=full","pubTime":"2024-12-05 10:10","pubTimestamp":1733364628,"startTime":"0","endTime":"0","summary":"一边回购一边被股东减持的甘李药业，被投资者这样质问。12月2日，甘李药业公告称，截至11月30日公司已累计回购股份39.69万股，耗资 1512.53万元。根据胡润2024年百富榜，甘忠如身家为105亿元。对于减持原因，甘李药业称旭特宏达系员工持股平台，减持是为满足已离职员工的退出资金需求。除了大比例现金分红之外，甘李药业还推出股份回购措施。目前，通化东宝和甘李药业为国内胰岛素双雄，分别是二代和三代胰岛素的龙头。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8f3pQWMimJs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2488951803","title":"概念掘金 | 医药巨头在华新建胰岛素生产基地，这些公司或成为“赢家”","url":"https://stock-news.laohu8.com/highlight/detail?id=2488951803","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488951803?lang=zh_cn&edition=full","pubTime":"2024-12-03 10:11","pubTimestamp":1733191895,"startTime":"0","endTime":"0","summary":"创造了公司在华最大单笔投资记录","market":"us","thumbnail":"https://img3.gelonghui.com/02fa1-16106239-1718-4fab-8750-6efec1b6d747.jpg?guru_height=3672&guru_width=5184","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/02fa1-16106239-1718-4fab-8750-6efec1b6d747.jpg?guru_height=3672&guru_width=5184"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1419204","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1161","601089","BK0209","LU1064131003.USD","600867","LU2488822045.USD","BK0239","603087","BK0188","BK0132","LU1064130708.USD","600276","LU1328615791.USD","BK1574","BK0012","LU2148510915.USD","BK0196","09939","BK0175","BK0187","LU1969619763.USD","BK0028","LU0405327494.USD","BK1515","LU0405327148.USD","BK0060","BK0183","LU2328871848.SGD","000963"],"gpt_icon":0},{"id":"2488620939","title":"甘李药业累计回购40万股，金额1513万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488620939","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488620939?lang=zh_cn&edition=full","pubTime":"2024-12-02 18:54","pubTimestamp":1733136861,"startTime":"0","endTime":"0","summary":"根据公告，公司于2024年9月5日开始实施回购方案，计划回购金额为1.5亿元至3亿元，回购期限为2024年9月5日至2025年9月4日。截止到2024年11月30日，公司已累计回购40万股，占总股本的0.0660%，累计回购金额为1513万元，实际回购价格区间为37.65元/股至38.42元/股。回购股份的进展情况符合相关法律法规及公司回购方案的要求。2024年前三季度，甘李药业实现收入22.45亿元，归母净利润5.07亿元。文章来源：财中社甘李药业累计回购40万股，金额1513万元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202191927abef9172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202191927abef9172&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2488616071","title":"甘李药业：公司前三季度营业收入22.45亿元，同比增长17.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488616071","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488616071?lang=zh_cn&edition=full","pubTime":"2024-12-02 09:07","pubTimestamp":1733101620,"startTime":"0","endTime":"0","summary":"来源：Gangtise投研甘李药业2024年第三季度报告显示：实现营业收入9.30亿元，同比增长37.61%，主要得益于国内制剂产品价格上涨以及国际市场拓展成效显著。国内收入增长稳健，同比增长22.25%，其中新一轮胰岛素集采价格上涨效应在三季度初步体现，带来1.50亿元收入增长。公司前三季度营业收入22.45亿元，同比增长17.81%，归属于上市公司股东的净利润5.07亿元，同比增长90.36%。经营活动现金流量净额4.65亿元，同比增长5.42亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202090759a264ccf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202090759a264ccf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087"],"gpt_icon":0},{"id":"2487539616","title":"甘李药业：公司胰岛素的增值税的税率为3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487539616","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487539616?lang=zh_cn&edition=full","pubTime":"2024-11-29 18:00","pubTimestamp":1732874414,"startTime":"0","endTime":"0","summary":"证券之星消息，甘李药业11月29日在投资者关系平台上答复投资者关心的问题。胰岛素甘李药业董秘：尊敬的投资者您好，公司胰岛素的增值税的税率为3%。甘李药业董秘：尊敬的投资者您好，公司于11月6日在上海证券交易所网站披露了《以集中竞价交易方式回购公司股份的进展公告》，截至2024年10月31日，公司已累计回购股价39.69万股，占公司总股本的0.0660%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112900030226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2486958573","title":"甘李药业11月28日现1笔大宗交易 成交金额204.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486958573","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486958573?lang=zh_cn&edition=full","pubTime":"2024-11-28 17:40","pubTimestamp":1732786800,"startTime":"0","endTime":"0","summary":"　　11月28日，甘李药业收跌0.22%，收盘价为45.50元，发生1笔大宗交易，合计成交量4.5万股，成交金额204.75万元。　　第1笔成交价格为45.50元，成交4.50万股，成交金额204.75万元，溢价率为0.00%，买方营业部为华泰证券股份有限公司总部，卖方营业部为中信证券股份有限公司上海分公司。　　进一步统计，近3个月内该股累计发生11笔大宗交易，合计成交金额为4454.77万元。该股近5个交易日累计下跌2.44%，主力资金合计净流出5791.3万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-11-28/doc-incxrfqr2904223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2486398481","title":"11月28日甘李药业现204.75万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2486398481","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486398481?lang=zh_cn&edition=full","pubTime":"2024-11-28 17:20","pubTimestamp":1732785656,"startTime":"0","endTime":"0","summary":"证券之星消息，11月28日甘李药业发生大宗交易，交易数据如下：大宗交易成交价格45.5元，成交4.5万股，成交金额204.75万元，买方营业部为华泰证券股份有限公司总部，卖方营业部为中信证券股份有限公司上海分公司。近三个月该股共发生11笔大宗交易，合计成交1.04万手，折价成交10笔。截至2024年11月28日收盘，甘李药业报收于45.5元，下跌0.22%，换手率0.87%，成交量4.81万手，成交额2.2亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112800029020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603087"],"gpt_icon":0},{"id":"2486636937","title":"甘李药业11月28日主力资金流入213万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2486636937","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486636937?lang=zh_cn&edition=full","pubTime":"2024-11-28 15:21","pubTimestamp":1732778464,"startTime":"0","endTime":"0","summary":"11月28日, 甘李药业股价跌0.22%，报收45.50元，成交金额2.20亿元，换手率0.87%，振幅1.29%，量比0.76。甘李药业今日主力资金净流入213万元，连续3日净流入，上一交易日主力净流入340万元，今日环比减少37.35%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为42.86%，平均涨幅为2.33%。该股近5个交易日下跌2.44%，主力资金累计净流出5536万元；近20日主力资金累计净流出3.37亿元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128154114a25bc750&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128154114a25bc750&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087","BK0239"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长，机构：医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上，据医保局日前披露，2024年1-10月医保统筹基金收入23065.07亿元，同比增长8.9%；2024年1-10月统筹支出19165.88亿元，同比增长8.9%。对此，国泰君安表示，1-10月医保统筹基金运行平稳，收入稳健增长，支出增速逐月收窄。国金证券表示，由于多方面因素，医药板块景气度在2021年后经历了长时间的下行。2024年11月7日，国家医保局召开了座谈会，强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","688091","688177","159938","600062","600763","688271","600196","688114","688192","600976","688266","600332","688690","688566","603567","600998","600085","688166","603590","600422","688382","688617","600771","688085","603108","600200","600867","600420","603367","688176","688658","688520","BK0070","600511","688321","688670","603233","688050","603658","603301","600535","603439","688428","688356","688389","688575","688247","688443","688278","600566","603087","688235","688105","688198","603896","600380","688029","603939","BK0185","688180","600285","688506","BK0012","600161","688161","600055","605199","688189","600436","688488","603707","688221","603127","688351","688578","688163","688202","600521","688193","688137","688046","688581","688076","600721","600851","600080","600488","688062","BK0188","BK0239","601607","688687","600529","688117","688067","600739","688331","603309","688767","688139","600252","688212","603456","BK0028","688222","688298","688373","600329","603259","688301","603882","600351","600056","600079","688656","688276","BK0096","688315","600276","603858","603538","600572","600129","688073","688336","605177","600211","688626"],"gpt_icon":0},{"id":"2486075548","title":"甘李药业国际业务部总监刘改：海外医药市场千亿美元缺口待补，如何获得定价权是关键｜聚焦2024华夏大健康大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486075548","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486075548?lang=zh_cn&edition=full","pubTime":"2024-11-26 19:12","pubTimestamp":1732619537,"startTime":"0","endTime":"0","summary":"在“中国 创新药 与器械企业出海过程中面临哪些机遇与挑战”圆桌论坛上， 甘李药业 国际业务部总监刘改表示，国产创新药出海正当其时。从国内情况来看，医药专利保护比较松散，定价机制对于利润也进行了严格地控制，出海是药企“不得不”做的一个选择，另一方面，海外市场吸引力巨大，MNC药企们众多专利面临过期，整个市场将出现千亿美元级别的缺口，这是中国创新药的绝佳机会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126191934abe05eac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126191934abe05eac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603087","159938","BK0239"],"gpt_icon":0},{"id":"2486099714","title":"甘李药业：第三季度营业收入9.30亿元，同比增长37.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486099714","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486099714?lang=zh_cn&edition=full","pubTime":"2024-11-26 09:33","pubTimestamp":1732584780,"startTime":"0","endTime":"0","summary":"　　甘李药业2024年第三季度报告显示：实现营业收入9.30亿元，同比增长37.61%，主要得益于国内制剂产品价格上涨以及国际市场拓展成效显著。国际销售收入同比增长72.10%，主要由于出口至阿尔及利亚的本土化项目成功落地。公司前三季度营业收入22.45亿元，同比增长17.81%，归属于上市公司股东的净利润5.07亿元，同比增长90.36%。经营活动现金流量净额4.65亿元，同比增长5.42亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-11-26/doc-incxkans7558591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603087"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-06-29","address":"北京市通州区漷县镇南凤西一路8号","stockEarnings":[{"period":"1week","weight":-0.0091},{"period":"1month","weight":-0.0161},{"period":"3month","weight":0.2159},{"period":"6month","weight":-0.0918},{"period":"1year","weight":-0.0985},{"period":"ytd","weight":-0.1175}],"companyName":"甘李药业股份有限公司","boardCode":"AI0027","perCapita":"7110股","boardName":"医药制造业","registeredCapital":"60106万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":"　　甘李药业股份有限公司主要从事重组胰岛素类似物原料药及注射剂的研发、生产和销售。公司主要产品包括重组甘精胰岛素注射液、重组赖脯胰岛素注射液、精蛋白锌重组赖脯胰岛素混合注射液、门冬胰岛素注射液、门冬胰岛素30注射液五个胰岛素类似物品种。公司为唯一掌握产业化生产重组胰岛素类似物技术的中国企业，使得我国成为世界上少数能进行重组胰岛素类似物产业化生产的国家之一。","serverTime":1734857695413,"listedPrice":63.32,"stockholders":"77899人(较上一季度减少5.90%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"甘李药业(603087)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供甘李药业(603087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"甘李药业,603087,甘李药业股票,甘李药业股票老虎,甘李药业股票老虎国际,甘李药业行情,甘李药业股票行情,甘李药业股价,甘李药业股市,甘李药业股票价格,甘李药业股票交易,甘李药业股票购买,甘李药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"甘李药业(603087)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供甘李药业(603087)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}